D.E. Shaw & Co’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,514,427
| Closed | -$129M | – | 4310 |
|
|
2020
Q3 | $129M | Buy |
1,514,427
+960,173
| +173% | +$48.6M | 0.13% | 167 |
|
|
2020
Q2 | $19.6M | Buy |
554,254
+136,325
| +33% | +$3.99M | 0.02% | 784 |
|
|
2020
Q1 | $5.63M | Sell |
417,929
-135,709
| -25% | -$2.28M | 0.01% | 1381 |
|
|
2019
Q4 | $11.7M | Buy |
553,638
+408,034
| +280% | +$7.2M | 0.01% | 1103 |
|
|
2019
Q3 | $1.93M | Buy |
145,604
+92,117
| +172% | +$1.35M | ﹤0.01% | 2379 |
|
|
2019
Q2 | $742K | Sell |
53,487
-1,687
| -3% | -$25.4K | ﹤0.01% | 2857 |
|
|
2019
Q1 | $1.06M | Buy |
+55,174
| New | +$889K | ﹤0.01% | 2576 |
|
|
2018
Q4 | – | Sell |
-31,464
| Closed | -$625K | – | 4111 |
|
|
2018
Q3 | $655K | Buy |
31,464
+11,890
| +61% | +$282K | ﹤0.01% | 2956 |
|
|
2018
Q2 | $463K | Sell |
19,574
-123,380
| -86% | -$2.48M | ﹤0.01% | 3162 |
|
|
2018
Q1 | $2.09M | Buy |
142,954
+99,563
| +229% | +$1.63M | ﹤0.01% | 2027 |
|
|
2017
Q4 | $701K | Buy |
43,391
+22,600
| +109% | +$267K | ﹤0.01% | 2776 |
|
|
2017
Q3 | $291K | Buy |
+20,791
| New | +$207K | ﹤0.01% | 3155 |
|
|
2017
Q2 | – | Sell |
-61,719
| Closed | -$433K | – | 3616 |
|
|
2017
Q1 | $399K | Buy |
+61,719
| New | +$313K | ﹤0.01% | 2840 |
|
|
2016
Q4 | – | Sell |
-18,400
| Closed | -$60K | – | 3684 |
|
|
2016
Q3 | $60K | Sell |
18,400
-400
| -2% | -$1.12K | ﹤0.01% | 3316 |
|
|
2016
Q2 | $44K | Buy |
+18,800
| New | +$62.8K | ﹤0.01% | 3291 |
|
|
2016
Q1 | – | Sell |
-170,134
| Closed | -$522K | – | 3905 |
|
|
2015
Q4 | $522K | Buy |
170,134
+91,917
| +118% | +$257K | ﹤0.01% | 3067 |
|
|
2015
Q3 | $135K | Sell |
78,217
-154,001
| -66% | -$393K | ﹤0.01% | 3578 |
|
|
2015
Q2 | $943K | Sell |
232,218
-26,760
| -10% | -$109K | ﹤0.01% | 2752 |
|
|
2015
Q1 | $992K | Buy |
258,978
+157,600
| +155% | +$685K | ﹤0.01% | 2564 |
|
|
2014
Q4 | $487K | Buy |
+101,378
| New | +$401K | ﹤0.01% | 3344 |
|
|
2014
Q2 | – | Sell |
-14,300
| Closed | -$60K | – | 4650 |
|
|
2014
Q1 | $60K | Buy |
+14,300
| New | +$70.9K | ﹤0.01% | 4197 |
|
D.E. Shaw & Co's IMMU Position: Q4 2020 in Review
D.E. Shaw & Co sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,514,427 shares — an estimated $129M sold.
D.E. Shaw & Co first reported a position in IMMU in Q1 2014 and held it in 21 quarters. The position peaked at $129M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- D.E. Shaw & Co reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- D.E. Shaw & Co sold 1,514,427 Immunomedics Inc shares in Q4 2020, an estimated $129M.
- D.E. Shaw & Co first reported a position in Immunomedics Inc in Q1 2014 and held it in 21 quarters.
- D.E. Shaw & Co's Immunomedics Inc position peaked at $129M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.